Molecular Medicine
BioMed Central Ltd Β· United Kingdom
β Indexed in the Web of Science Core Collection (SCIE) β Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.
See the official Impact Factor & quartile on the journalβs page βThe Impact Factor & JCR quartile are licensed by Clarivate β we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.
Aims & Scope
Molecular Medicine is an open access journal publishing recent findings that elucidate disease pathogenesis at the molecular or physiological level, which may lead to the design of specific tools for disease diagnosis, treatment, or prevention. Manuscripts containing material relevant to the genetic, molecular, or cellular basis of key physiologic or disease processes are considered for publication. Manuscripts submitted to Molecular Medicine should describe the implications of the results for human disease and medicine, at a level approachable by our broad audience. Criteria to consider for studies involving lnc-RNAs or micro-RNAs: Β· As lncRNAs and miRNAs have multiple targets, claims of their function mediated by a single target or pathway will not be accepted, unless multiple additional targets are investigated to support functional specificity. Β· The rationale to investigate a specific lncRNA or miRNA needs to be specified upfront in the introduction and justified in the context of other miRNAs known to be functional in that specific field. Β· The proposed function of the lnc-RNA or miRNA should be validated by gain and loss of function studies. Β· Primary cells should be used whenever possible to confirm findings in cell lines. Β· In depth investigation in the signaling pathway(s) regulated by the RNA species should be conducted. Β· Insight into the regulation of the RNA species and how it relates to the pathologic state should be provided. Β· If applicable: Details of initial screen used to identify RNA species involvement in pathway/disease (number of subjects, statistical tests employed, percent change from controls).
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Source: OpenAlex Β· Each yearβs green bar = citations earned by that yearβs papers, counted to date β so recent years look lower simply because their papers havenβt had time to be cited yet.
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category β its quartile can differ by discipline.
Subject Classification
Web of Science Categories
Scopus Categories
Research Topics (OpenAlex)
Frequently asked questions about Molecular Medicine
Is Molecular Medicine a predatory journal?
PubScope has no integrity flags on record for Molecular Medicine: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee β always confirm fit and policies before submitting.
What is the impact factor of Molecular Medicine?
Molecular Medicine is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β including Arts & Humanities and Emerging Sources titles β receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 6.55.
Is Molecular Medicine indexed in Scopus and Web of Science?
Molecular Medicine is indexed in Web of Science, Scopus, DOAJ.
What is the aims and scope of Molecular Medicine?
Molecular Medicine is an open access journal publishing recent findings that elucidate disease pathogenesis at the molecular or physiological level, which may lead to the design of specific tools for disease diagnosis, treatment, or prevention. Manuscripts containing material relevant to the genetic, molecular, or cellular basis of key physiologic or disease processes are considered for publication. Manuscripts submitted to Molecular Medicine should describe the implications of the results for human disease and medicine, at a level approachable by our broad audience. Criteria to consider for s
You May Also Like
See all βData updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref